We explore joint scientific consultations; what they mean and why they are important to manufacturer...
Read moreAmong the most expensive therapies are gene therapies that show promise to transform inherited disor...
Read moreThe provision of funding for Early Access Programmes is not ubiquitous. We explore which EU5 countri...
Read moreIn a phase 3 study, Crovalimab was found to be efficacious and well tolerated in people with paroxys...
Read moreOur experts provide an overview of the five key trends that could shape the pricing and market acces...
Read moreIntroduction: Brazil is a market of 210 million people Brazil is the largest country in South Americ...
Read moreEUCOPE notes that “while these proposals don’t necessarily represent the final options included ...
Read moreAdvanced therapy medicinal products (ATMPs) are medicinal products for human use that are based on l...
Read moreThe 2021 Social Security Law made provision for overhauling the early scheme in France. As of 1st Ju...
Read moreThe HST process is a method for evaluating medicines and treatments specifically indicated for ultra...
Read more